Business
Immutep (ASX:IMM) share price hikes amid clinical trial momentum in FY21
Image source: Getty Images
Shares in clinical stage biotechnology company Immutep Ltd (ASX: IMM) are inching higher in afternoon trading, up 2.5% to 62 cents apiece.
Immutep’s share price has been on the move amid the release of its annual report today, in which several investment…
Continue Reading
-
Business23 hours agoHow to turn a $50,000 ASX share portfolio into a passive income machine
-
General22 hours agoMortgage belt hoping lower inflation heralds rate cut
-
Business14 hours agoIf I could only own 1 ASX retailer for the next 5 years it would be this one
-
Noosa News17 hours agoTownsville hosts inaugural roadshow – Proctor